SUMO1P1
Small ubiquitin-related modifier 5
Also known as: SUMO5_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for SUMO1P1 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
101 residues, UniProt reviewed canonical sequence.
>G2XKQ0|SUMO1P1
1 MSDLEAKPST EHLGDKIKDE DIKLRVIGQD SSEIHFKVKM TTPLKKLKKS YCQRQGVPVN
61 SLRFLFEGQR IADNHTPEEL GMEEEDVIEV YQEQIGGHST VLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SUMO1P1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SUMO1P1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SUMO1P1 as an antibody target. Whether an autoantibody or antibody against SUMO1P1 could matter depends on whether native SUMO1P1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SUMO1P1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SUMO1P1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...